Overview

So-Lo-Mo Intervention Applied to the Smoking Cessation Process

Status:
Completed
Trial end date:
2018-10-24
Target enrollment:
Participant gender:
Summary
This is a randomized open-label parallel-group trial. 240 subjects will be recruited during 8 months and a 12 months follow-up will be carried out for each one of them. The sample will split in two groups: control group (n=120) who will receive usual psycho-pharmacological therapy and the intervention group (n=120) who will receive usual therapy plus So-Lo-Mo app.
Phase:
N/A
Details
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Collaborators:
Andaluz Health Service
European Commission
Treatments:
Bupropion
Varenicline